Dragonfly Therapeutics, Inc., Waltham, MA, USA.
Department of Chemistry and Chemical Biology, Barnett Institute for Chemical and Biological Analysis, Northeastern University, Boston, MA, USA.
MAbs. 2024 Jan-Dec;16(1):2433121. doi: 10.1080/19420862.2024.2433121. Epub 2024 Nov 25.
Natural killer (NK) cells are effector cells of the innate immune system that distinguish between healthy and abnormal cells through activating and inhibitory receptor signaling. NKG2D, a homodimeric activating receptor expressed on NK cells, recognizes a diverse class of stress ligands expressed by cells experiencing infection, malignant transformation, chronic inflammation, and other cellular stresses. Despite the variety of NKG2D ligands, they all bind the receptor asymmetrically in a 1:1 ligand to homodimeric NKG2D stoichiometry. In contrast, as we report herein, the agonistic antibody 2D3 binds NKG2D with a 2:1 stoichiometry of its antigen binding fragments to homodimeric NKG2D and a largely distinct epitope. This binding interaction, as compared to NKG2D natural ligands, suggests there may be unique mechanisms to engage this receptor while offering possible benefits when incorporated into an IgG-based therapeutic.
自然杀伤 (NK) 细胞是先天免疫系统的效应细胞,通过激活和抑制受体信号来区分健康细胞和异常细胞。NKG2D 是一种表达在 NK 细胞上的同二聚体激活受体,识别细胞经历感染、恶性转化、慢性炎症和其他细胞应激时表达的多种应激配体。尽管 NKG2D 配体种类繁多,但它们都以不对称的方式结合受体,以 1:1 的配体与同二聚体 NKG2D 计量比结合。相比之下,正如我们在此报告的那样,激动性抗体 2D3 以其抗原结合片段与同二聚体 NKG2D 的 2:1 计量比结合,并与一个截然不同的表位结合。与 NKG2D 天然配体相比,这种结合相互作用表明,在将其纳入 IgG 为基础的治疗药物时,可能存在独特的机制来结合该受体,同时提供可能的益处。